Grace Therapeutics Inc.
XNAS: GRCE
Grace Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart
about
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for t...
Read More
2.98
-0.05
(-1.65%)
62,687
XNAS Volume
XNAS 29 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Grace Therapeutics Inc. is on 08 Aug 2025 for the purpose of Acasti Pharma Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Grace Therapeutics Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..